Qualigen Therapeutics, Inc. (Nasdaq: QLGN)
2042 Corte del Nogal
Carlsbad, CA 92011
The Clinical Development leader will report to the Executive Vice President, Chief Strategy Officer and be responsible for overseeing drug candidate programs for Qualigen Therapeutic’s oncology pipeline programs. The VP Clinical Development will define strategy and drive implementation of drug development and scientific communications. In addition, the VP, Clinical Development, Oncology will lead clinical science aspects of design, execution, interpretation and reporting of clinical trials in collaboration with CROs. Manuscript writing and submission, and presentation of data (to KOLs, shareholders, investors, analysts, potential partners) will also be an important component of the incumbent’s responsibilities. This clinical role serves as the company’s medical expert to develop and execute medical/scientific strategy, including scientific evidence generation and scientific information exchange with key stakeholders. The Vice President Clinical Development will exemplify collaboration in a progressive culture that puts patients first while delivering shareholder value.
The position will encompass responsibility for both internal and external stakeholders.
Internal stakeholders include the CEO, Chief Strategy Officer, Project Management Team, Leadership Team, Board of Directors, while external commitments include those to CROs, Consultants, Analysts and Investors, potential and existing Partners, and Thought Leaders.
Please forward CV, resume, and correspondence to email@example.com